The Patent Finder

Entasis Therapeutics Limited

12 patents currently held · Updated Nov 18, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Oct 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 26, 2026
    The maintenance fee for Chemical Compounds 542 (US 9,040,528) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
  • 1 fee due Feb 13, 2027
    The maintenance fee for Combination Therapy for Treatment of Resistant Bacterial Infections (US 10,376,499) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
  • 1 fee due May 17, 2027
    The maintenance fee for Compounds and Methods for Treating Bacterial Infections (US 9,187,495) comes due May 17, 2027. Unpaid by Nov 17, 2027, it lapses early.
  • 1 fee due Oct 12, 2027
    The maintenance fee for Beta-Lactamase Inhibitor Compounds (US 9,309,245) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,040,528Chemical Compounds 542
In force
 · Medium confidence
In forceMedium confidence
US 8,658,641Fused, Spirocyclic Heteroaromatic Compounds for the Treatment of Bacterial Infections
In force
 · High confidence
In forceHigh confidence
US 9,309,245Beta-Lactamase Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
US 8,889,671Compounds and Methods for Treating Bacterial Infections
In force
 · High confidence
In forceHigh confidence
US 9,187,495Compounds and Methods for Treating Bacterial Infections
In force
 · Medium confidence
In forceMedium confidence
US 9,540,394Compounds and Methods for Treating Bacterial Infections
In force
 · Medium confidence
In forceMedium confidence
US 9,839,641Compounds and Methods for Treating Bacterial Infections
In force
 · Medium confidence
In forceMedium confidence
US 9,968,593Combination Therapy for Treatment of Resistant Bacterial Infections
In force
 · High confidence
In forceHigh confidence
US 10,376,499Combination Therapy for Treatment of Resistant Bacterial Infections
In force
 · High confidence
In forceHigh confidence
US 10,800,778Beta-Lactamase Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
Also on record, not counted in the 12: 1 patent in force now held by others · 4 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited